Details for New Drug Application (NDA): 040833
✉ Email this page to a colleague
NDA 040833 describes ERGOCALCIFEROL, which is a drug marketed by Chartwell Rx, Puracap Pharm Llc, Sigmapharm Labs Llc, Strides Pharma, and Sun Pharm Inds Inc, and is included in five NDAs. It is available from seventeen suppliers. Additional details are available on the ERGOCALCIFEROL profile page.
The generic ingredient in ERGOCALCIFEROL is ergocalciferol. There are six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ergocalciferol profile page.
The generic ingredient in ERGOCALCIFEROL is ergocalciferol. There are six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ergocalciferol profile page.
Summary for 040833
| Tradename: | ERGOCALCIFEROL |
| Applicant: | Chartwell Rx |
| Ingredient: | ergocalciferol |
| Patents: | 0 |
Suppliers and Packaging for NDA: 040833
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ERGOCALCIFEROL | ergocalciferol | CAPSULE;ORAL | 040833 | ANDA | Aphena Pharma Solutions - Tennessee, LLC | 43353-219 | 43353-219-03 | 3 CAPSULE in 1 BOTTLE, PLASTIC (43353-219-03) |
| ERGOCALCIFEROL | ergocalciferol | CAPSULE;ORAL | 040833 | ANDA | Aphena Pharma Solutions - Tennessee, LLC | 43353-219 | 43353-219-04 | 4 CAPSULE in 1 BOTTLE, PLASTIC (43353-219-04) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50,000 IU | ||||
| Approval Date: | May 20, 2009 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
